• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    The Hidden Puppeteer: Binance's Alleged Covert Control Over Binance.US Accounts Draws Scrutiny

    6/5/23 10:13:54 AM ET
    $SI
    Medical/Dental Instruments
    Health Care
    Get the next $SI alert in real time by email

    High-ranking Binance executive Guangying Chen, a trusted ally of Binance CEO Changpeng Zhao, was the principal controller of five bank accounts associated with the supposedly autonomous U.S. subsidiary of the colossal crypto exchange, Binance.US, according to disclosed bank records.

    Among these accounts, one contained funds belonging to American clients, Reuters reported.

    These accounts, under the stewardship of Chen, were approved by U.S. financial institution Silvergate Bank (NYSE:SI) in 2019 and 2020, the documents from these periods revealed.

    Consequently, Chen and her subordinates were given the authorization to mobilize funds in these bank accounts.

    To execute payments, even for payroll, the staff of the U.S. arm, Binance.US, had to approach Chen's team.

    Previously undisclosed bank records and communications depict the extent of this clandestine control exerted by Binance over its U.S. arm's financial operations, particularly regarding its Silvergate bank accounts.

    However, Binance.US rebuffs claims of Binance ever controlling its bank accounts.

    The company's legal head, Krishna Juvvadi, told Reuters in April that since its inception in 2019, BAM Trading, the operator of Binance.US, had exclusive control.

    In a recent response, Binance.US spokesperson Christian Hertenstein, stated that only Binance.US officials have had control or access to Binance.US accounts since the current CEO Brian Shroder assumed office in late 2021. The differing timelines given by Juvvadi and Hertenstein went unexplained.

    Benzinga has independently reached out to Binance for a comment.

    Also Read: Crypto Industry Experts Say Hong Kong And UAE Collaboration On Regulations Is A Game Changer

    The report further states that Zhao covertly maintained financial control over Binance.US, directing its expansion into the substantial American crypto market while keeping it distinct from his global exchange, which has attracted regulatory attention from the U.S.

    Binance and Zhao were accused of deliberate evasion of commodities laws by the U.S. Commodity Futures Trading Commission in March, allegedly through "intentional structuring of entities" to circumvent U.S. regulations meant to safeguard investors.

    Zhao denounced these civil charges as a "partial representation of facts." 

    In 2021, it was reported that over $400 million was transferred from a Binance.US Silvergate account, managed by a Chen deputy, to a Zhao-controlled trading company, Merit Peak.

    Binance.US, however, claimed that Merit Peak was merely withdrawing its funds, derived from its exchange trading activity.

    A Binance.US investigation into the previous allegations found them "entirely false," according to Juvvadi.

    Binance was also accused of blending customer funds with its corporate revenues in Merit Peak's Silvergate account, contravening U.S. financial regulations mandating separate client funds.

    This accusation was vehemently denied by Binance.

    Guangying Chen, also known as Heina, took on the role of "Primary Admin User" for the five bank accounts as per agreements with Silvergate Bank, with bank records dating between December 2019 and January 2020 backing this claim.

    Binance.US was not in control of its financial affairs due to this arrangement.

    Binance.US continued to assert its independence and autonomy from Binance, stating that any issues related to Chen's role, her control over the accounts, and when it might have ended are "difficult to address in their entirety" due to a complete change in the management team since the period in question.

    Read Next: Coinbase Shakes Up The Crypto World With Bitcoin And Ethereum Futures Rollout

    Photo: Web Summit on flickr

    Get the next $SI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SI

    DatePrice TargetRatingAnalyst
    8/25/2025$20.00Buy
    Goldman
    8/25/2025$23.00Buy
    BTIG Research
    8/25/2025$18.00Overweight
    Piper Sandler
    8/25/2025$19.00Buy
    Jefferies
    3/6/2023Neutral → Sell
    Compass Point
    3/6/2023$9.00 → $4.00Neutral → Underperform
    Wedbush
    3/2/2023$16.00 → $10.00Buy → Neutral
    Compass Point
    3/2/2023Neutral → Underweight
    JP Morgan
    More analyst ratings

    $SI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Goldman initiated coverage on Shoulder Innovations with a new price target

    Goldman initiated coverage of Shoulder Innovations with a rating of Buy and set a new price target of $20.00

    8/25/25 8:23:10 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Piper Sandler initiated coverage on Shoulder Innovations with a new price target

    Piper Sandler initiated coverage of Shoulder Innovations with a rating of Overweight and set a new price target of $18.00

    8/25/25 8:22:49 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    BTIG Research initiated coverage on Shoulder Innovations with a new price target

    BTIG Research initiated coverage of Shoulder Innovations with a rating of Buy and set a new price target of $23.00

    8/25/25 8:22:49 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    $SI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    CEO & Executive Chairman Ball Robert Joseph exercised 12,062 shares at a strike of $2.42, increasing direct ownership by 5% to 276,666 units (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    2/10/26 4:24:26 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Chief Financial Officer Points Jeffrey S.

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    2/3/26 4:43:22 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Officer Blue David Lawrence

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    2/3/26 4:39:36 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    $SI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Financial Officer Points Jeffrey S. bought $29,632 worth of shares (2,000 units at $14.82), increasing direct ownership by 4% to 54,445 units (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    12/15/25 4:57:01 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    CEO & Executive Chairman Ball Robert Joseph bought $107,009 worth of shares (7,200 units at $14.86), increasing direct ownership by 6% to 118,457 units (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    12/15/25 4:51:45 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    CHIEF FINANCIAL OFFICER Points Jeffrey S. exercised 13,264 shares at a strike of $2.48 and bought $25,072 worth of shares (1,600 units at $15.67), increasing direct ownership by 40% to 52,445 units (SEC Form 4)

    4 - SHOULDER INNOVATIONS, INC. (0001699350) (Issuer)

    9/15/25 4:25:01 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    $SI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Shoulder Innovations Appoints MedTech Veteran Drew Hykes to Board of Directors

    GRAND RAPIDS, Mich., March 2, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced the appointment of Drew Hykes to the company's Board of Directors ("Board") and as a member of the Compensation Committee, effective February 26, 2026. Concurrent with Mr. Hykes's appointment, Geoff Pardo will resign as an Independent Director from the Board.   "Drew is a proven healthcare leader, and we are thrilled to welcome him to S

    3/2/26 7:00:00 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Shoulder Innovations to Participate in the Canaccord Genuity 2026 Musculoskeletal Conference

    GRAND RAPIDS, Mich., Feb. 18, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced that members of management will present at the Canaccord Genuity 2026 Musculoskeletal Conference. The presentation will take place at 2:00 p.m. CT / 12:00 p.m. PT on Tuesday, March 3, 2026.   A live and archived version of the presentation will be available on the "Investor Relations" section of the Shoulder Innovations website at https

    2/18/26 4:05:00 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Shoulder Innovations to Report Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026

    GRAND RAPIDS, Mich., Feb. 12, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the fourth quarter and full year of 2025 after market close on Tuesday, March 10, 2026. Management will host a conference call to discuss financial results beginning at 4:30 p.m. ET / 1:30 p.m. PT on March 10, 2026. Those interested in listening to the conference call may do so by dialing (877) 40

    2/12/26 4:05:00 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    $SI
    SEC Filings

    View All

    Shoulder Innovations Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)

    3/2/26 7:07:44 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Shoulder Innovations Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)

    12/3/25 7:10:53 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    SEC Form 10-Q filed by Shoulder Innovations Inc.

    10-Q - SHOULDER INNOVATIONS, INC. (0001699350) (Filer)

    11/12/25 4:10:24 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    $SI
    Financials

    Live finance-specific insights

    View All

    Shoulder Innovations to Report Fourth Quarter and Full Year 2025 Financial Results on March 10, 2026

    GRAND RAPIDS, Mich., Feb. 12, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the fourth quarter and full year of 2025 after market close on Tuesday, March 10, 2026. Management will host a conference call to discuss financial results beginning at 4:30 p.m. ET / 1:30 p.m. PT on March 10, 2026. Those interested in listening to the conference call may do so by dialing (877) 40

    2/12/26 4:05:00 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Shoulder Innovations to Report Third Quarter 2025 Financial Results on November 11, 2025

    GRAND RAPIDS, Mich., Oct. 20, 2025 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the third quarter of 2025 after market close on Tuesday, November 11, 2025. Management will host a conference call to discuss financial results beginning at 4:30 p.m. ET / 1:30 p.m. PT on November 11, 2025. Those interested in listening to the conference call may do so by dialing (877) 407-8216 fo

    10/20/25 4:05:00 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Shoulder Innovations to Report Second Quarter 2025 Financial Results on September 9, 2025

    Company to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference on the Same Day GRAND RAPIDS, Mich., Aug. 28, 2025 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced it will release financial results for the second quarter of 2025 before market open on Tuesday, September 9, 2025. On the same day, members of management will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Hea

    8/28/25 4:05:00 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    $SI
    Leadership Updates

    Live Leadership Updates

    View All

    Shoulder Innovations Appoints MedTech Veteran Drew Hykes to Board of Directors

    GRAND RAPIDS, Mich., March 2, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. ("Shoulder Innovations") (NYSE:SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today announced the appointment of Drew Hykes to the company's Board of Directors ("Board") and as a member of the Compensation Committee, effective February 26, 2026. Concurrent with Mr. Hykes's appointment, Geoff Pardo will resign as an Independent Director from the Board.   "Drew is a proven healthcare leader, and we are thrilled to welcome him to S

    3/2/26 7:00:00 AM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Silvergate announces changes to its executive team

    Silvergate Capital Corporation (the "Company" or "Silvergate") (NYSE:SI), the leading provider of innovative financial infrastructure solutions to the digital asset industry, today announced the promotion of Ben Reynolds to President, and appointment of Kate Fraher as Chief Risk Officer, of both the Company and its subsidiary, Silvergate Bank. In their new roles, Ben and Kate will continue reporting to Alan Lane, CEO of Silvergate and the bank. "We are excited about these new roles, which will benefit Silvergate as we continue to grow and mature as an organization," said Alan Lane, CEO of Silvergate. "Serving the digital asset industry requires that we continue to innovate and deliver prod

    11/7/22 4:30:00 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    Silvergate Announces Appointment of Mary-Margaret Henke to Board of Directors

    Silvergate Capital Corporation (the "Company" or "Silvergate") (NYSE:SI), the leading provider of innovative financial infrastructure solutions to the digital currency industry, today announced the appointment of Mary-Margaret Henke to the board of directors of both the Company and its subsidiary bank, Silvergate Bank. "I am fortunate to be joining Silvergate's board during this period of continued evolution for both the bank and the digital assets industry," said Mary-Margaret Henke. "I look forward to working in tandem with my fellow Board members and management to ensure the Company remains a leader in innovative banking solutions." "Mary-Margaret's extensive knowledge of the financial

    9/19/22 4:15:00 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    $SI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Silvergate Capital Corporation (Amendment)

    SC 13G/A - Silvergate Capital Corp (0001312109) (Subject)

    2/12/24 12:17:13 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Silvergate Capital Corporation (Amendment)

    SC 13G/A - Silvergate Capital Corp (0001312109) (Subject)

    5/22/23 4:03:17 PM ET
    $SI
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G filed by Silvergate Capital Corporation

    SC 13G - Silvergate Capital Corp (0001312109) (Subject)

    2/14/23 4:49:34 PM ET
    $SI
    Medical/Dental Instruments
    Health Care